Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News
  • Published:

Biotrin assay to monitor cervical cancer exposure rates

Screening for serotypes will insure success of immunization programs against HPV.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Author information

Authors and Affiliations

Authors

Related links

Related links

Related links in Nature Research

Nature Reviews Drug Discovery, 5 629 - 630 (01 Aug 2006) News and Analysis

https://doi.org/10.1038/News@Nature12,721-721(01Jul2006)News

Web links

Biotrin

World Health Organization

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sheridan, C. Biotrin assay to monitor cervical cancer exposure rates. Nat Biotechnol 25, 6 (2007). https://doi.org/10.1038/nbt0107-6

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/nbt0107-6

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing